Effect of Glucagon-like peptide-1 agonist (liriglutide) on weight and glycemic control among adults with type 2 diabetes mellitus attending primary care center at security forces hospital in Riyadh, Saudi Arabia

INTRODUCTION: Liraglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist), also known as incretin mimetics. This is the new approach for management of weight among diabetic patients along with glycemic controls. The study aims to explore the efficacy of Liraglutide on weight (...

Descripción completa

Detalles Bibliográficos
Autores principales: Alanazi, Naifah K., Ghoraba, Medhat A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586614/
https://www.ncbi.nlm.nih.gov/pubmed/33110789
http://dx.doi.org/10.4103/jfmpc.jfmpc_361_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586614/
https://www.ncbi.nlm.nih.gov/pubmed/33110789
http://dx.doi.org/10.4103/jfmpc.jfmpc_361_20

Ejemplares similares